Errant Gene Therapeutics’ Gene Therapy Vector Shows Promise for Sickle Cell Disease and Thalassemia Patients

Errant Gene Therapeutics’ Gene Therapy Vector Shows Promise for Sickle Cell Disease and Thalassemia Patients

The abstract submitted to the European Hematology Association by Dr. Simona Raso for a new analysis of the safety and efficacy of Errant Gene Therapeutics’ vector, technically “human globin TNS9.3.55,” shows promising results and potentially offers newfound hope for the 1.8 million worldwide who suffer from the rare diseases Sickle Cell Anemia and Thalassemia. The study analyzes the use of the EGT vector on three patients at Memorial Sloan Kettering from 2012 to 2015, with a five to seven-year follow-up. 

Although a small investigational effort, two out of three patients examined had a sustained reduction in blood transfusions of 44%, and no unwanted clonal dominance was found. EGT emphasizes that reduced transfusions are a huge decrease in various risks to the patient. EGT notes that they made “the world’s first commercial batch of gene therapy vector” in 2009, and this was used in the study. Today, making tweaks, which is commonplace, using anti-sicklers, insulators, enhancers, improved filtration, and other prep regimen drugs, EGT believes that the vector they produced in 2009 could meet, if not surpass, any competitor today at a far less cost for patients. Dr...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee